TrialMayo Clinic proceedings2011

MAP0004, orally inhaled dihydroergotamine for acute treatment of migraine: efficacy of early and late treatments.

Stewart J Tepper et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.